The global veterinary endoscopy market size in 2026 is estimated at USD 332.95 million, growing from 2025 value of USD 310.15 million with 2031 projections showing USD 475.1 million, growing at 7.35% CAGR over 2026-2031. This report is Segmented by Product Type (Endoscopes, Visualization & Imaging Systems, and More), Procedure (Diagnostic and Therapeutic), Application (Gastrointestinal, Urogenital, and More), Animal Type (Companion Animals and Livestock), End User (Veterinary Hospitals & Referral Clinics, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Complementary visualization consoles and integrated AI analytics represent the second-largest revenue pool, driven by system upgrades rather than new room builds. Accessory sales - biopsy forceps, snares, retrieval baskets - generate high-margin recurring income for OEMs. The segment benefits as therapeutic procedure counts climb, knitting consumable pull-through to each intervention.
Diagnostic work comprised 63.40% of global cases in 2025, supported by superior mucosal assessment over radiography. High tissue-sampling accuracy reduces exploratory surgeries and informs targeted pharmacologic regimens, reinforcing demand. Still, therapeutic endoscopy is the momentum engine, projected to log a 10.1% CAGR through 2031 as scope channels widen and accessory toolkits diversify. Stricture dilations, polyp resections, and foreign-body retrievals now performable in a single anesthetic window drive client acceptance. Combined diagnostic-therapeutic workflows compress visit counts, appealing to busy pet owners and reducing stress on animals. Manufacturers responding with torque-stable overtubes and laser-compatible working channels stand to capture the fastest-growing pocket of the veterinary endoscopy market.
Europe ranks second by value, buttressed by stringent welfare regulations and long-established referral networks. Germany’s engineering pedigree supports local OEM production, driving early adoption of robotic articulating scopes. The United Kingdom combines strong pet-ownership culture with robust specialty certification, fostering high per-capita procedure volumes. Mediterranean countries lag Northern peers but close gaps swiftly as specialty hospitals proliferate.
Asia-Pacific is the locomotive of global growth, slated for a 9.1% CAGR through 2031. China’s expanding middle class elevates pet medical spend, stimulating multi-site hospital chains that can amortize endoscope investments. Japan showcases advanced technique maturity, while India’s growth stems from a low base but benefits from rising urban pet populations and Western educational collaborations. Australia and South Korea sustain high-quality benchmarks, but intra-regional disparity persists as rural sectors remain underserved.
South America and the Middle East & Africa represent smaller shares yet register healthy growth as veterinary colleges upgrade curricula and corporates enter metropolitan markets. Equipment donation programs and tele-endoscopy partnerships mitigate specialist shortages, further unlocking latent demand.
Global Veterinary Endoscopy Market Trends and Insights
Rising Gastrointestinal and Respiratory Disorders
Growing incidence of chronic enteropathies, inflammatory bowel disease, and lower airway disease is prompting veterinarians to adopt endoscopy as first-line diagnostics. Practices report measurably higher diagnostic yields versus radiography; one study recorded a 37% uptick in definitive GI diagnoses when endoscopy was deployed. Prolonged companion-animal lifespans also expose more animals to age-related GI pathologies, further swelling procedure volumes. Large-animal practitioners increasingly use upper airway endoscopy for racehorses and bronchoscopy for dairy herds, broadening demand beyond companion clinics. Together, these clinical trends are raising throughput and justifying equipment investment across the veterinary endoscopy market.Pet Humanization and Premium Care Spend
Households without children are channeling discretionary income toward advanced companion-animal healthcare, reinforcing willingness to pay for endoscopic diagnostics and minimally invasive therapy. Morgan Stanley projects annual household pet outlays to hit USD 1,733 by 2030, with veterinary services the fastest-expanding line item. High-definition video and capsule modalities align well with owner preferences for gentle, low-scarring interventions. The converging influence of insured procedures and third-party financing platforms is also reducing upfront cost sensitivity, allowing specialty centers to market comprehensive endoscopic packages. Consequently, pet humanization continues to boost procedure frequency and revenue across the veterinary endoscopy market.High Equipment Costs Limiting Adoption
Entry-level HD systems can exceed USD 45,000, a hurdle for small or rural clinics battling declining foot traffic and thinning margins. Service contracts, scope repair, and specialty cleaning units add to lifecycle outlays, lengthening payback periods. Emerging-market practices face even steeper import duties and limited financing, stalling penetration of the veterinary endoscopy market. Vendors offering pay-per-use or leasing models are attempting to ease adoption, yet overall budget constraints remain a strong drag on market growth.Other drivers and restraints analyzed in the detailed report include:
- Technological Miniaturization Expanding Accessibility
- Tele-Endoscopy and Cloud-Based Image Management
- Veterinary Endoscopist Shortage
Segment Analysis
Flexible video systems delivered 45.30% of 2025 revenue, underscoring their versatility in GI, respiratory, and urogenital work. HD chip-on-tip optics provide crisp imagery, while variable stiffness insertion tubes improve maneuverability. Correspondingly, the segment captured the largest slice of the veterinary endoscopy market share. Capsule modules, although accounting for lower absolute revenue, post an 11.2% CAGR as clinics embrace anesthesia-free imaging for cats, small dogs, and exotics. The veterinary endoscopy market size for capsule devices is on track to more than double by 2030. Rigid scopes retain popularity in arthroscopy owing to durable optics and tactile control, and robot-assisted units, though nascent, attract premium equine centers exploring remote joystick manipulation.Complementary visualization consoles and integrated AI analytics represent the second-largest revenue pool, driven by system upgrades rather than new room builds. Accessory sales - biopsy forceps, snares, retrieval baskets - generate high-margin recurring income for OEMs. The segment benefits as therapeutic procedure counts climb, knitting consumable pull-through to each intervention.
Diagnostic work comprised 63.40% of global cases in 2025, supported by superior mucosal assessment over radiography. High tissue-sampling accuracy reduces exploratory surgeries and informs targeted pharmacologic regimens, reinforcing demand. Still, therapeutic endoscopy is the momentum engine, projected to log a 10.1% CAGR through 2031 as scope channels widen and accessory toolkits diversify. Stricture dilations, polyp resections, and foreign-body retrievals now performable in a single anesthetic window drive client acceptance. Combined diagnostic-therapeutic workflows compress visit counts, appealing to busy pet owners and reducing stress on animals. Manufacturers responding with torque-stable overtubes and laser-compatible working channels stand to capture the fastest-growing pocket of the veterinary endoscopy market.
Complete Report Scope:
- By Product Type
- Endoscopes
- Capsule
- Flexible Video
- Rigid
- Robot-assisted
- Visualization & Imaging Systems
- Accessories & Consumables
- Endoscopes
- By Procedure
- Diagnostic
- Therapeutic / Interventional
- By Application
- Gastrointestinal
- Respiratory & ENT
- Urogenital
- Orthopedic / Arthroscopy
- Others
- By Animal Type
- Companion Animals
- Canine
- Feline
- Equine
- Livestock
- Bovine
- Porcine
- Poultry
- Ovine/Caprine
- Companion Animals
- By End User
- Veterinary Hospitals & Referral Clinics
- Ambulatory & Specialty Centers
- Academic & Research Institutes
- Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America contributed 37.60% of 2025 global revenue, cementing regional supremacy for the veterinary endoscopy market. High pet insurance uptake and the world’s densest population of diplomate-level specialists sustain premium procedure demand. U.S. referral hospitals spearhead adoption of capsule and 4K imaging, while Canadian clinics lean on university affiliations for complex case overflow. Mexico’s urban corridors exhibit double-digit growth as middle-income households pivot toward Western pet-care norms.Europe ranks second by value, buttressed by stringent welfare regulations and long-established referral networks. Germany’s engineering pedigree supports local OEM production, driving early adoption of robotic articulating scopes. The United Kingdom combines strong pet-ownership culture with robust specialty certification, fostering high per-capita procedure volumes. Mediterranean countries lag Northern peers but close gaps swiftly as specialty hospitals proliferate.
Asia-Pacific is the locomotive of global growth, slated for a 9.1% CAGR through 2031. China’s expanding middle class elevates pet medical spend, stimulating multi-site hospital chains that can amortize endoscope investments. Japan showcases advanced technique maturity, while India’s growth stems from a low base but benefits from rising urban pet populations and Western educational collaborations. Australia and South Korea sustain high-quality benchmarks, but intra-regional disparity persists as rural sectors remain underserved.
South America and the Middle East & Africa represent smaller shares yet register healthy growth as veterinary colleges upgrade curricula and corporates enter metropolitan markets. Equipment donation programs and tele-endoscopy partnerships mitigate specialist shortages, further unlocking latent demand.
List of Companies Covered in this Report:
- Biovision Veterinary Endoscopy
- Karl Storz
- Olympus
- Medtronic
- STERIS
- Dr. Fritz Endoscopy
- Eickemeyer Veterinary Equipment
- Zhuhai Seesheen Medical Technology
- Fujifilm Holdings Corp.
- SonoScape Medical Corp.
- Cook Group
- Endoscopy Support Services Inc.
- VetOvation
- Arthrex Vet Systems
- Jorgensen Laboratories
- Hill-Rom Holdings (Welch Allyn Vet)
- iM3 Veterinary
- B. Braun
- TianSong Medical Instrument
- Medit Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts (Value, USD)
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biovision Veterinary Endoscopy LLC
- Karl Storz SE & Co. KG
- Olympus Corporation
- Medtronic PLC
- Steris PLC
- Dr. Fritz Endoscopy GmbH
- Eickemeyer Veterinary Equipment
- Zhuhai Seesheen Medical Technology
- Fujifilm Holdings Corp.
- SonoScape Medical Corp.
- Cook Medical
- Endoscopy Support Services Inc.
- VetOvation
- Arthrex Vet Systems
- Jorgensen Laboratories
- Hill-Rom Holdings (Welch Allyn Vet)
- iM3 Veterinary
- B. Braun Melsungen AG
- TianSong Medical Instrument
- Medit Inc.
